![Mark W. Durand](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark W. Durand
Nessuna posizione attualmente
Profilo
Mark W.
Durand formerly worked at ERBA Diagnostics, Inc., as Director from 2006 to 2008, Bristol Myers Squibb Co., as Vice President-Finance & Business Development from 1987 to 2004, Actavis, Inc., as Chief Financial Officer & Senior Vice President from 2007 to 2009, Teva North America, as CFO, Senior VP-Finance & Business Development in 2011, and Sorrento Therapeutics, Inc., as Chief Financial Officer & Executive Vice President in 2015.
Mr. Durand received his graduate degree in 1984 from Dartmouth College, undergraduate degree in 1981 from Duke University, and Masters Business Admin degree in 1986 from The University of Chicago.
Precedenti posizioni note di Mark W. Durand
Società | Posizione | Fine |
---|---|---|
SORRENTO THERAPEUTICS, INC. | Direttore Finanziario/CFO | 23/06/2015 |
Actavis, Inc.
![]() Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Direttore Finanziario/CFO | 27/07/2009 |
ERBA DIAGNOSTICS, INC. | Direttore/Membro del Consiglio | 02/09/2008 |
BRISTOL-MYERS SQUIBB COMPANY | Direttore Finanziario/CFO | 01/01/2004 |
Teva North America | Direttore Finanziario/CFO | - |
Formazione di Mark W. Durand
Duke University | Undergraduate Degree |
Dartmouth College | Graduate Degree |
The University of Chicago | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
SORRENTO THERAPEUTICS, INC. | Health Technology |
Aziende private | 3 |
---|---|
ERBA Diagnostics, Inc.
![]() ERBA Diagnostics, Inc. Medical SpecialtiesHealth Technology ERBA Diagnostics, Inc. was engaged in manufacturing and marketing of proprietary diagnostic reagents, test kits and instrumentation in the areas of autoimmune, chemistry, hematology, diabetes, and infectious diseases. The company was founded in 1980 and was headquartered in Miami Lakes, FL. | Health Technology |
Teva North America | |
Actavis, Inc.
![]() Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Health Technology |
- Borsa valori
- Insiders
- Mark W. Durand